Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,081,655
+$1,818,022 QoQ
Shares Held
59,787
+36.5% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $3,424,927,095 across 37 Diagnostics & Research names. GRAL ranks #20 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,430,798 | $1,720,064,877 | |
| 2 | DHR |
Danaher Corp /De/
|
2,393,859 | $455,982,255 | |
| 3 | LH |
Labcorp Holdings Inc.
|
807,619 | $226,133,320 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
797,956 | $154,181,053 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
274,340 | $144,423,545 | |
| 6 | A |
Agilent Technologies, Inc.
|
835,556 | $110,986,898 | |
| 7 | WAT |
Waters Corp /De/
|
267,531 | $100,334,819 | |
| 8 | NTRA |
Natera, Inc.
|
295,159 | $80,120,905 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,081,655 | 59,787 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,263,633 | 43,801 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,650,529 | 54,335 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,650,387 | 61,735 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,686,245 | 71,689 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $2,249,610 | 88,082 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,335,499 | 74,818 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,045,701 | 75,996 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $869,844 | 56,594 | Shares | Defined | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||